Clinical Trial: A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07656415) titled 'A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)' on June 15.

Brief Summary: The primary objective of this study is to determine the effect of mitapivat versus placebo on the need for transfusions in subjects with SCD.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Sickle Cell Disease

Intervention: DRUG: Mitapivat Matched Placebo

Tablets

DRUG: Mitapivat

Tablets

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Agios Pharmaceuticals, Inc.

Disclaimer: Curated by HT Syndication....